Clinical Trial Update: Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zanubrutinib combined with R-CHOP for newly diagnosed intravascular large B-cell lymphoma is being conducted; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intravascular Large B-cell Lymphoma

Drugs mentioned

• R-CHOP
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Intravascular Large B-Cell Lymphoma | Phase 2 | Status: UNKNOWN